Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors
Open accessThe DOI matches its Crossref record; 86 of the 89 references it cites were found in a registry or an index.
Abstract
Sequence-specific DNA binding proteins that function as transcription factors are frequently encoded by gene families. Such proteins display highly conserved DNA binding properties, yet are expected to retain promoter selectivity. In this report we investigate this problem using the ets gene family, a group of metazoan genes whose members regulate cell growth and differentiation and are mutated in human cancers. We tested whether the level of mRNA can serve as a specificity determinant. The mRNA levels of the 27 paralogous human ets genes were measured in 23 tissues and cell lines. Real-time RT-PCR provided accurate measurement of absolute mRNA levels for each gene down to one copy per cell. Surprisingly, at least 16 paralogs were expressed in each cell sample and over half were expressed ubiquitously. Tissues and complementary cell lines showed similar expression patterns, indicating that tissue complexity was not a limitation. There was no unique, highly expressed gene for each cell type. Instead, one of only eight ets genes showed the highest expression in all samples. DNA binding studies illustrate both overlapping and unique specificities for ubiquitous ETS proteins. These findings establish the parameters of the promoter specificity dilemma within the ets family of transcription factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In any particular cell type, 14 to 25 family members are coexpressed.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Half of the family members are ubiquitously expressed in all cell types tested.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [34]
In the citing paper
“In spite of the biological and biochemical evidence that different ETS proteins can execute diverse roles, an extensive overlap in the expression of various family members is found in many human tissues.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [34]
In the citing paper
“Expression profiles in transformed cell lines show strong similarity to those in matching normal tissues, although exceptions are worth noting.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems
Bustin, S. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290023 · Cited by 2,546
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Gene Expression Profiles in Normal and Cancer Cells
Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.276.5316.1268 · Cited by 1,184
Golub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 1×
“1 HL-60, lung Spleen, testis (30,31,79) Embryonic lethal, no myeloid or lymphoid differentiation (80,81) SPIB Raji, Spleen Lymphocytes-particularly mature B cells (31) B-cell defects (82) SPIC Spleen Spleen and lymph nodes (32) E1AF HCT116, HeLa, HepG2, HMEC, PC3, HL-60 Tissues in branching morphogenesis (83); Brain,…”
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Forkhead Transcription Factors: Key Players in Development and Metabolism
Carlsson, P., & Mahlapuu, M. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0780 · Cited by 840
Ternary complex factors: growth factor regulated transcriptional activators
Treisman, R. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90097-3 · Cited by 676
Takahashi, Y., Rayman, J. B., & Dynlacht, B. D. (2000) · Genes & Development · doi:10.1101/gad.14.7.804 · Cited by 621 · cited 1×
“was prepared and PCR was performed as described previously (23) with the following primers; albumin 50 ggtatgcctggcccaagtactc; 30 gatccctgtcccacatgtacaaagc; 50 EGR1 cttatttgggcagcaccttatttgg; 30 ggatccgcctctatttgaagg; CDC2L2 primers as described previously (24).”
Research works printed but not linked: 3
- [2]2. Graves,B.J. and Petersen,J.M. (1998) In Woude,G.V. and Klein,G. (eds), Advances in Cancer Research . Academic Press, San Diego, Vol. 75, pp. 1-55.
- [17]17. Rozen,S. and Skaletsky,H.J. (2000) In Krawetz,S. and Misener,S. (eds), Bioinformatics Methods and Protocols: Methods in Molecular Biology . Humana Press, Totowa, NJ, pp. 365-386.
- [22]22. Gunther,C.V. (1994) Regulation of Moloney Murine Retrovirus Transcription by the ETS gene family. PhD Thesis, University of Utah, UT, USA.
Cited by
Items 101–200 of 214
Critical Requirement of GABPα for Normal T Cell Development
Yu, S., Zhao, D., Jothi, R., & Xue, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088740 · Cited by 31
Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1
Xiang, P., Lo, C., Argiropoulos, B., Lai, C. B., ROUHI, A. M., Imren, S., Jiang, X., Mager, D. L., & Humphries, R. K. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.06.006 · Cited by 32
Poon, G. M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.342345 · Cited by 34
Bras, A. L., Samson, C., Trentini, M., Caëtano, B., Lelièvre, E., Mattot, V., Beermann, F., & Soncin, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012156 · Cited by 30
Asano, Y., & Trojanowska, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074930 · Cited by 27
Recent advances in animal models of systemic sclerosis
Asano, Y. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13185 · Cited by 27
Signatures of DNA target selectivity by ETS transcription factors
Poon, G. M. K., & Kim, H. M. (2017) · Transcription · doi:10.1080/21541264.2017.1302901 · Cited by 30
Mutant p53 and ETS2, a Tale of Reciprocity
Martinez, L. A. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00035 · Cited by 29
Presnell, S. R. (2006) · International Immunology · doi:10.1093/intimm/dxl043 · Cited by 26
Highly Cooperative Recruitment of Ets-1 and Release of Autoinhibition by Pax5
Fitzsimmons, D., Lukin, K., Lutz, R., Garvie, C. W., Wolberger, C., & Hagman, J. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.028 · Cited by 25
“4a-b, recruitment of Ets-1(331– 440) by Pax5(1-149)WT or Q22A occurred at different KDs (0.”
BackgroundAnalysis of select members of the E26 (ETS) transcription factors family in colorectal cancer
Deves, C., Renck, D., Garicochea, B., da Silva, V. D., Lopes, T. G., Fillman, H., Fillman, L., Alves, S. L., Basso, L. A., Santos, D. S., et al. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1053-6 · Cited by 28
Probing chromatin landscape reveals roles of endocardial TBX20 in septation
Boogerd, C. J. J., Aneas, I., Sakabe, N. J., Dirschinger, R. J., Cheng, Q. J., Zhou, B., Chen, J., Nóbrega, M. A., & Evans, S. Μ. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85350 · Cited by 25
Kerr, N. C. H., Pintzas, A., Holmes, F. E., Hobson, S., Pope, R. J. P., Wallace, M., Wasylyk, C., Wasylyk, B., & Wynick, D. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.03.005 · Cited by 24
Plotnik, J. P., & Hollenhorst, P. C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx039 · Cited by 24
Self-citationStrempel, J. M., Grenningloh, R., Ho, I., & Vercelli, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804162 · Cited by 28
Wei, Y., Han, S., Wen, J., Liao, J., Liang, J., Yu, J., Chen, X., Xiang, S., Huang, Z., & Zhang, B. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00909-3 · Cited by 28
ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression
Watson, D. K., Turner, D. P., Scheiber, M. N., Findlay, V. J., & Watson, P. M. (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010024 · Cited by 30
Xiao, J., Yang, S., Shen, P., Wang, Y., Sun, H., Ji, F., & Zhou, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.163 · Cited by 23
MicroRNA 17-92 Cluster Mediates ETS1 and ETS2-Dependent RAS-Oncogenic Transformation
Kabbout, M., Dakhlallah, D. A., Sharma, S. M., Bronisz, A., Srinivasan, R., Piper, M. G., Marsh, C. B., & Ostrowski, M. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100693 · Cited by 25
The mouse and human Fli1 genes are similarly regulated by Ets factors in T cells
Svenson, J. L., Chike-Harris, K. E., Amria, M. Y., & Nowling, T. K. (2009) · Genes and Immunity · doi:10.1038/gene.2009.73 · Cited by 22
Ets transcription factors regulate AIRE gene promoter
Murumägi, A., Silvennoinen, O., & Peterson, P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.135 · Cited by 22
ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease
Lee, D. H., Kim, T. M., Kim, J. K., & Park, C. (2019) · Theranostics · doi:10.7150/thno.35300 · Cited by 20
DNA selection by the master transcription factor PU.1
Terrell, J. R., Taylor, S. J., Schneider, A. L., Lu, Y., Vernon, T. N., Xhani, S., Gumpper, R. H., Luo, M., Wilson, W. D., Steidl, U. G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112671 · Cited by 25
Regulation of the human LAT gene by the Elf-1 transcription factor
Finco, T. S., Justice, G. E., Patel, S. J., & Hamilton, V. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-4 · Cited by 22
Role of Ets Proteins in Development, Differentiation, and Function of T‐Cell Subsets
Liu, M., Gao, W., van Velkinburgh, J. C., Wu, Y., Ni, B., & Tian, Y. (2015) · Medicinal Research Reviews · doi:10.1002/med.21361 · Cited by 24
EndothelialErgexpression is required for embryogenesis and vascular integrity
Han, R., Pacifici, M., Iwamoto, M., & Trojanowska, M. (2015) · Organogenesis · doi:10.1080/15476278.2015.1031435 · Cited by 23
Sugi, Y., Takahashi, K., Nakano, K., Hosono, A., & Kaminogawa, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.035 · Cited by 20
Madison, B. J., Clark, K. A., Bhachech, N., Hollenhorst, P. C., Graves, B. J., & Currie, S. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003352 · Cited by 22
Self-citationVascular Potential of Human Pluripotent Stem Cells
Iacobas, I., Vats, A., & Hirschi, K. K. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191601 · Cited by 19
Newman, J. A., Cooper, C. D. O., Aitkenhead, H., & Gileadi, O. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.619270 · Cited by 19
Wernert, N. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.672 · Cited by 18
Kathuria, H., Cao, Y. X., Hinds, A., Ramirez, M. I., & Williams, M. C. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21270 · Cited by 18
EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells
Gao, L., Yang, T., Zhang, S., Liang, Y., Shi, P., Ren, H. J., Hou, P., & Chen, M. (2021) · Oncology Reports · doi:10.3892/or.2021.8053 · Cited by 17
Millien, G., Cao, Y. X., O’Hara, C., Tagne, J., Hinds, A., Williams, M. C., Ramirez, M. I., & Kathuria, H. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9912-z · Cited by 16
Ubiquitin-Mediated Control of ETS Transcription Factors: Roles in Cancer and Development
Ducker, C. E., & Shaw, P. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105119 · Cited by 18
The obesity-associated transcription factor ETV5 modulates circulating glucocorticoids
Gutiérrez‐Aguilar, R., Thompson, A. K., Marchand, N., Dumont, P., Woods, S. C., de Launoit, Y., Seeley, R. J., & Ulrich‐Lai, Y. M. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.03.027 · Cited by 16
Sood, A. K., Kim, H. L., & Geradts, J. (2011) · The Prostate · doi:10.1002/pros.21461 · Cited by 23
Expression of master regulatory genes of embryonic development in pancreatic tumors
Kondratyeva, L. G., Чернов, И. П., Zinovyeva, M. V., Kopantzev, E. P., & Sverdlov, E. D. (2017) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672917040020 · Cited by 15
Liu, H., Duan, Z., Zheng, H., Hu, D., Li, M., Tao, Y., Bode, A. M., Dong, Z., & Cao, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032624 · Cited by 16
BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway
Cao, P., Zhao, S., Sun, Z., Jiang, N., Shang, Y., Wang, Y., Gu, J., & Li, S. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.08.013 · Cited by 17
Confirming the Functional Importance of a Protein–DNA Interaction
Carey, M., Peterson, C. L., & Smale, S. T. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top070060 · Cited by 17
Regulation of protein tyrosine kinases in tumour cells by the transcription factor Ets-1
Wernert (2009) · International Journal of Oncology · doi:10.3892/ijo_00000413 · Cited by 17
Tyulkina, D. V., Pleshkan, V. V., Алексеенко, И. В., Kopantseva, M. R., & Sverdlov, E. D. (2016) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672916050033 · Cited by 15
Wei, G., Brockdorff, N., & Zhang, T. (2020) · iScience · doi:10.1016/j.isci.2020.101741 · Cited by 13
Hahne, J. C., Fuchs, T., Haddouti, E.-M., Okuducu, A. F., Bories, J. C., & Wernert, N. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.1.153 · Cited by 13
Jedlicka, P., Sui, X., Sussel, L., & Gutierrez‐Hartmann, A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080409 · Cited by 15
Noda, S., Asano, Y., Akamata, K., Aozasa, N., Taniguchi, T., Takahashi, T., Ichimura, Y., Toyama, T., Sumida, H., Yanaba, K., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11055.x · Cited by 12
Prostate-derived Ets factor, an oncogenic driver in breast cancer
Sood, A. K., Geradts, J., & Young, J. S. (2017) · Tumor Biology · doi:10.1177/1010428317691688 · Cited by 12
Yamashita, K., Kawasaki, A., Matsushita, T., Furukawa, H., Kondo, Y., Okiyama, N., Nagaoka, S., Shimada, K., Sugii, S., Katayama, M., et al. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa306 · Cited by 12
Wang, F., Koul, S., Shanmugam, P. S. T., Dong, Q., & Koul, H. K. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0010 · Cited by 11
Endothelial Cell Differentiation and Hemogenic Specification
Aragon, J. W., & Hirschi, K. K. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041164 · Cited by 15
KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma
Jia, D., Wang, P., Zheng, S. L., Lei, Z., Xu, W., Wang, Y., Pan, X., Feng, Q., & Yang, J.-L. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102525 · Cited by 12
Cao, Q., Yang, S., Lv, Q., Liu, Y., Li, L., Wu, X., Qu, G., He, X., Zhang, X., Sun, S., et al. (2018) · Aging · doi:10.18632/aging.101475 · Cited by 10
Kitazono, I., Hamada, T., Yoshimura, T., Kirishima, M., Yokoyama, S., Akahane, T., & Tanimoto, A. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0462-z · Cited by 10
Iwata, Y., Matsuno, N., Ishii, D., Toriumi, A., Otani, M., Ohara, M., OBARA, H., Nishikawa, Y., & Yokoo, H. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16140 · Cited by 9
Transactivation of lung lysozyme expression by Ets family member ESE-1
Lei, W., Jaramillo, R. J., & Harrod, K. S. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00130.2007 · Cited by 8
Li, B., Wan, X., Zhu, Q., Li, L., Zeng, Y., Hu, D., Qian, Y., Lu, L., Wang, X., & Meng, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057818 · Cited by 9
RetractedPresnell, S. R., Zhang, L., Chlebowy, C. N., Al‐Attar, A., & Lutz, C. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103352 · Cited by 9
CDK1 inhibition reduces osteogenesis in endothelial cells in vascular calcification
Zhao, Y., Yang, Y., Wu, X., Zhang, L., Cai, X., Ji, J., Chen, S., Vera, A., Boström, K. I., & Yao, Y. (2024) · JCI Insight · doi:10.1172/jci.insight.176065 · Cited by 8
Animal Models of Cutaneous and Hepatic Fibrosis
Smith, G. P. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00011-1 · Cited by 10
Zhao, H., Xu, C., Lee, T., Liu, F., & Choi, K. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24483 · Cited by 8
Fli1 Is a Negative Regulator of Estrogen Receptor α in Dermal Fibroblasts
Hattori, T., Stawski, L., Nakerakanti, S. S., & Trojanowska, M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.63 · Cited by 9
Wernert, N. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.771 · Cited by 8
Chromatin Marks and Machines, the Missing Nucleosome Is a Theme
Carey, M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.013 · Cited by 7
A unified and self-reinforcing mechanism of tumor cell immortality
Stevers, N. O., Kim, S., Yuan, J. B., Barger, C. J., Hong, C., Lenzo, O., McKinney, A., Wu, S. H., Lee, Y. J., Kwok, D. W., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2025.05.026 · Cited by 8
ETS-Related Gene Expression in Healthy Femoral Arteries With Focal Calcifications
Vasuri, F., Valente, S., Motta, I., Degiovanni, A., Ciavarella, C., & Pasquinelli, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.623782 · Cited by 6
What can we learn from Fli1 -deficient mice, new animal models of systemic sclerosis?
Asano, Y. (2018) · Journal of Scleroderma and Related Disorders · doi:10.1177/2397198318758221 · Cited by 7
von Brandenstein, M., Schlosser, M., Richter, C., Depping, R., & Fries, J. W. U. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.04.014 · Cited by 6
ERG-Mediated Cell Invasion: A Link between Development and Tumorigenesis
Blee, A. M., & Huang, H. (2015) · Medical Epigenetics · doi:10.1159/000440978 · Cited by 7
ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer
Shaikhibrahim, Z., OCHSENFAHRT, J., Fuchs, K., Kristiansen, G., Perner, S., & Wernert, N. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1097 · Cited by 5
The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice
Jedlicka, P., Sui, X., & Gutierrez‐Hartmann, A. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-197 · Cited by 5
Animal Models of Fibrosis in Human Disease
Smith, G. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00019-1 · Cited by 8
Sood, A. K. (2009) · Immunologic Research · doi:10.1007/s12026-009-8129-2 · Cited by 5
The Impact of Endothelial Transcription Factors in Sprouting Angiogenesis
Hofmann, M., & Heineke, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-31215-6_38-1 · Cited by 6
Role of Transcription Factor Fli-1 in Inflammation and Autoimmune Diseases
Wang, X., & Zhang, X. K. (2025) · Biomolecules · doi:10.3390/biom15040480 · Cited by 5
Schafer, C. C., Young, D., Singh, H., Jayakrishnan, R., Banerjee, S., Song, Y., Dobi, A. L., Petrovics, G., Srivastava, S., Srivastava, S. K., et al. (2023) · Journal of Immunological Methods · doi:10.1016/j.jim.2023.113493 · Cited by 4
Evaluation of effects caused by differentially spliced Ets-1 transcripts in fibroblasts
Wernert, N. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1152 · Cited by 5
ESE-1 in Early Development: Approaches for the Future
Lee, C. M., Wu, J., Xia, Y., & Hu, J. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00073 · Cited by 3
Niu, W., Li, G., Zhang, T., & Ma, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-71285-7 · Cited by 2
Paiva, E., Orr, B., Azeredo, A., Brandão, A., Teixeira, M. R., & Paulo, P. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70069 · Cited by 4
Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines
Wernert, N. (2012) · Oncology Reports · doi:10.3892/or.2012.1667 · Cited by 2
The Impact of Endothelial Transcription Factors in Sprouting Angiogenesis
Hofmann, M., & Heineke, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_38 · Cited by 3
Kearly, A., Saelee, P., Bard, J., Sinha, S., Satterthwaite, A. B., & Garrett‐Sinha, L. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0308896 · Cited by 1
Krzystek‐Korpacka, M., Korpacki, A., Wąsowicz, A., & Neubauer, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188359 · Cited by 1
Suwa, Y., Nakamura, T., Toma, Š., Ikemizu, S., Kai, H., & Yamagata, Y. (2008) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309108002662 · Cited by 1
Odrowaz, Z., & Sharrocks, A. D. (2011) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000830.01 · Cited by 1
The Pattern of Epithelial Carcinogenesis
Méndez-López, L. F., de la Garza, A. L., & Lomelí, M. L.-C. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_324 · Cited by 1
Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes
Caceres, R. A., Nunes, C. P., de Azevedo, W. F., Basso, L. A., & Santos, D. S. (2007) · Current Bioinformatics · doi:10.2174/157489307781662141 · Cited by 1
From Molecular Biology to Epithelial CarcinogenesisPreprint
Méndez-López, L. F. (2021) · Preprints.org · doi:10.20944/preprints202107.0090.v1
Role of P73 in endothelial cell differentation, vasculogenesis and angiogenesis
Alonso, R. F. (2013) · Buleria (Universidad de León) · doi:10.18002/10612/2882
Identification and Function of Ets Target Genes Involved in Lung Cancer Progression
Kathuria, H. (2011) · Defense Technical Information Center (DTIC) · doi:10.21236/ada555912
Endothelial Transcriptional Networks in the Control of Angiogenesis: the ETS Factor
RANDI, A. M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1428-5_6
Transcription saga tells developmental stories
Graves, B. J., & Tamkun, J. W. (2006) · Development · doi:10.1242/dev.02639
Phenotypic Impact of ETV4 overxpression in prostate carcinogenesis
Mesquita, D. S. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/1hfs-sz79
The Role and Regulation of Etv2 in Zebrafish Vascular Development: A Dissertation
Moore, J. C. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m21k56
Hypoxia in arterial and venous specification during vascular development
Sohl, M. (2009) · Figshare
Transcriptional regulation of FEV, a human serotonin neuron developmental control gene
Krueger, K. C. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Becker‐Santos, D. D. (2011) · Open Collections · doi:10.14288/1.0071651
The Transcription Factor ERG is a Gatekeeper of Endothelial Cell Homeostasis
Dryden, N. H. (2012) · Spiral (Imperial College London) · doi:10.25560/9798
Metadata
- Authors
- Hollenhorst, P. C.
- Affiliations
- University of Utah (US)
- Corresponding author
- Hollenhorst, P. C.
- ORCID
- Hollenhorst, P. C.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-10-11
- Volume
- 32
- Issue
- 18
- Pages
- 5693-5702
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC524310
- OpenAlex
- W2113086329
- Cited by
- 214
- References
- 89
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 3 · 2023: 7 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 6 · 2018: 10 · 2017: 12 · 2016: 14 · 2015: 16 · 2014: 7 · 2013: 12 · 2012: 16
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA24014, T32CA093247, T32 CA 93247, P30CA042014)
- National Institute of General Medical Sciences (GM 38663, R01GM038663)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- ETS transcription factors, promoter specificity, gene expression profiling, mRNA levels, paralogs, DNA binding specificity, tissue-specific gene expression, cell growth and differentiation, cancer mutations
- MeSH terms
- Binding Sites, Cell Line, DNA, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proto-Oncogene Proteins, RNA, Messenger, Transcription Factors, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Proto-Oncogene Proteins c-ets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.